PHARMA
Quarterly rpt on consolidated results for the financial period ended 31/12/2012
PHARMANIAGA BERHAD |
Financial Year End | 31/12/2012 |
Quarter | 4 |
Quarterly report for the financial period ended | 31/12/2012 |
The figures | have not been audited |
Remarks : |
The Basic Earnings per Share ("EPS") for the preceding year corresponding quarter and period, and Net Assets per Share for the preceding financial year end have been restated to reflect the retrospective adjustments arising from the bonus issue which was completed on 20 February 2012 and adoption of Malaysian Financial Reporting Standards. |
- Default Currency
- Other Currency
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION31/12/2012 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
31/12/2012 | 31/12/2011 | 31/12/2012 | 31/12/2011 | ||
$$'000 | $$'000 | $$'000 | $$'000 | ||
1 | Revenue | 482,404 | 367,786 | 1,812,346 | 1,520,981 |
2 | Profit/(loss) before tax | 4,248 | 16,368 | 103,313 | 73,186 |
3 | Profit/(loss) for the period | -7,468 | 12,182 | 63,205 | 52,785 |
4 | Profit/(loss) attributable to ordinary equity holders of the parent | -7,934 | 11,942 | 61,710 | 52,157 |
5 | Basic earnings/(loss) per share (Subunit) | -6.74 | 10.15 | 52.44 | 44.32 |
6 | Proposed/Declared dividend per share (Subunit) | 10.00 | 30.00 | 35.00 | 30.00 |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
7 | Net assets per share attributable to ordinary equity holders of the parent ($$) | 4.0100 | 3.9600 |
Definition of Subunit:
In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
Country | Base Unit | Subunit |
Malaysia | Ringgit | Sen |
United States | Dollar | Cent |
United Kingdom | Pound | Pence |
Announcement Info
Company Name | PHARMANIAGA BERHAD |
Stock Name | PHARMA |
Date Announced | 18 Feb 2013 |
Category | Financial Results |
Reference No | PB-130206-32871 |